Macquarie Group’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $137M | Buy |
1,082,366
+71,760
| +7% | +$9.45M | 0.59% | 28 |
|
|
2026
Q1 | $141M | Sell |
1,010,606
-98,542
| -9% | -$13.8M | 0.84% | 19 |
|
|
2025
Q4 | $136M | Sell |
1,109,148
-479,391
| -30% | -$58.3M | 0.6% | 25 |
|
|
2025
Q3 | $176M | Buy |
1,588,539
+146,312
| +10% | +$16.6M | 0.21% | 84 |
|
|
2025
Q2 | $160M | Sell |
1,442,227
-59,485
| -4% | -$6.33M | 0.2% | 99 |
|
|
2025
Q1 | $168M | Buy |
1,501,712
+46,878
| +3% | +$4.84M | 0.21% | 109 |
|
|
2024
Q4 | $130M | Buy |
1,454,834
+60,957
| +4% | +$5.49M | 0.16% | 176 |
|
|
2024
Q3 | $117M | Buy |
1,393,877
+152,296
| +12% | +$11.6M | 0.13% | 222 |
|
|
2024
Q2 | $85.2M | Sell |
1,241,581
-17,203
| -1% | -$1.15M | 0.1% | 269 |
|
|
2024
Q1 | $92.2M | Buy |
1,258,784
+5,592
| +0.4% | +$430K | 0.1% | 256 |
|
|
2023
Q4 | $102M | Buy |
1,253,192
+82,982
| +7% | +$6.46M | 0.12% | 243 |
|
|
2023
Q3 | $87.7M | Buy |
1,170,210
+8,411
| +0.7% | +$647K | 0.11% | 250 |
|
|
2023
Q2 | $89.5M | Sell |
1,161,799
-23,903
| -2% | -$1.91M | 0.1% | 260 |
|
|
2023
Q1 | $98.4M | Buy |
1,185,702
+55,231
| +5% | +$4.57M | 0.12% | 235 |
|
|
2022
Q4 | $97.1M | Buy |
1,130,471
+12,401
| +1% | +$982K | 0.11% | 250 |
|
|
2022
Q3 | $69M | Buy |
1,118,070
+12,509
| +1% | +$789K | 0.08% | 326 |
|
|
2022
Q2 | $68.3M | Sell |
1,105,561
-3,884
| -0.4% | -$240K | 0.08% | 357 |
|
|
2022
Q1 | $66K | Buy |
1,109,445
+459,138
| +71% | +$29.3M | 0.05% | 430 |
|
|
2021
Q4 | $47.2M | Buy |
650,307
+4,284
| +0.7% | +$295K | 0.04% | 534 |
|
|
2021
Q3 | $45.1M | Buy |
646,023
+277,434
| +75% | +$19.5M | 0.04% | 559 |
|
|
2021
Q2 | $25.4M | Buy |
368,589
+112,970
| +44% | +$7.54M | 0.02% | 714 |
|
|
2021
Q1 | $16.5M | Sell |
255,619
-110,145
| -30% | -$7.1M | 0.02% | 593 |
|
|
2020
Q4 | $21.3M | Buy |
365,764
+6,000
| +2% | +$362K | 0.03% | 498 |
|
|
2020
Q3 | $22.7M | Buy |
359,764
+22,409
| +7% | +$1.55M | 0.04% | 437 |
|
|
2020
Q2 | $26M | Sell |
337,355
-76,376
| -18% | -$5.85M | 0.04% | 412 |
|
|
2020
Q1 | $30.9M | Buy |
413,731
+14,395
| +4% | +$995K | 0.06% | 317 |
|
|
2019
Q4 | $25.9M | Buy |
399,336
+5,806
| +1% | +$378K | 0.04% | 444 |
|
|
2019
Q3 | $24.9M | Sell |
393,530
-805
| -0.2% | -$52.6K | 0.04% | 400 |
|
|
2019
Q2 | $26.6M | Sell |
394,335
-8,777
| -2% | -$577K | 0.04% | 389 |
|
|
2019
Q1 | $26.2M | Sell |
403,112
-17,197
| -4% | -$1.14M | 0.04% | 405 |
|
|
2018
Q4 | $26.3M | Sell |
420,309
-22,993
| -5% | -$1.61M | 0.05% | 366 |
|
|
2018
Q3 | $34.2M | Buy |
443,302
+28,450
| +7% | +$2.15M | 0.06% | 356 |
|
|
2018
Q2 | $29.4M | Buy |
414,852
+29,375
| +8% | +$2.07M | 0.05% | 391 |
|
|
2018
Q1 | $29.1M | Sell |
385,477
-9,677
| -2% | -$769K | 0.05% | 377 |
|
|
2017
Q4 | $27.7M | Sell |
395,154
-84,178
| -18% | -$6.39M | 0.05% | 393 |
|
|
2017
Q3 | $38.8M | Buy |
479,332
+100,741
| +27% | +$7.7M | 0.07% | 275 |
|
|
2017
Q2 | $26.8M | Sell |
378,591
-59,556
| -14% | -$3.96M | 0.05% | 376 |
|
|
2017
Q1 | $29.8M | Sell |
438,147
-54,603
| -11% | -$3.84M | 0.05% | 340 |
|
|
2016
Q4 | $35.3M | Sell |
492,750
-18,391
| -4% | -$1.37M | 0.07% | 261 |
|
|
2016
Q3 | $40.4M | Sell |
511,141
-655,093
| -56% | -$53.2M | 0.08% | 228 |
|
|
2016
Q2 | $97.3M | Buy |
1,166,234
+535,550
| +85% | +$47.5M | 0.1% | 171 |
|
|
2016
Q1 | $57.9M | Sell |
630,684
-63,653
| -9% | -$5.74M | 0.12% | 136 |
|
|
2015
Q4 | $70.3M | Sell |
694,337
-53,070
| -7% | -$5.52M | 0.14% | 116 |
|
|
2015
Q3 | $73.4M | Sell |
747,407
-4,997
| -0.7% | -$555K | 0.16% | 112 |
|
|
2015
Q2 | $88.1M | Sell |
752,404
-266,895
| -26% | -$29.2M | 0.17% | 110 |
|
|
2015
Q1 | $100M | Sell |
1,019,299
-10,269
| -1% | -$1.04M | 0.2% | 100 |
|
|
2014
Q4 | $97M | Sell |
1,029,568
-92,044
| -8% | -$9.52M | 0.2% | 98 |
|
|
2014
Q3 | $119M | Sell |
1,121,612
-147,993
| -12% | -$14.5M | 0.26% | 88 |
|
|
2014
Q2 | $105M | Buy |
1,269,605
+224,375
| +21% | +$17.5M | 0.23% | 101 |
|
|
2014
Q1 | $74.1M | Sell |
1,045,230
-34,651
| -3% | -$2.72M | 0.13% | 128 |
|
|
2013
Q4 | $81.1M | Sell |
1,079,881
-7,023
| -0.6% | -$489K | 0.15% | 117 |
|
|
2013
Q3 | $68.3M | Sell |
1,086,904
-56,485
| -5% | -$3.38M | 0.13% | 123 |
|
|
2013
Q2 | $58.6M | Buy |
+1,143,389
| New | +$59.6M | 0.13% | 130 |
|
Other funds holding GILD
Macquarie Group's GILD Position: Q2 2026 in Review
Macquarie Group increased its Gilead Sciences (GILD) stake by 7.1% in Q2 2026, buying an estimated $9.45M and bringing the position to 1,082,366 shares worth $137M. The position accounts for 0.59% of the portfolio, ranked #28.
Macquarie Group first reported a position in GILD in Q2 2013 and has held it in 53 quarters since. The position peaked at $176M in Q3 2025. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Macquarie Group held 1,082,366 shares of Gilead Sciences worth $137M as of Q2 2026.
- Macquarie Group bought 71,760 Gilead Sciences shares in Q2 2026, an estimated $9.45M.
- Gilead Sciences made up 0.59% of Macquarie Group's portfolio in Q2 2026, its #28 holding.
- Macquarie Group first reported a position in Gilead Sciences in Q2 2013 and has held it in 53 quarters since.
- Macquarie Group's Gilead Sciences position peaked at $176M in Q3 2025.
- 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Macquarie Group's 13F filing for Q2 2026, filed 14 Aug 2026.